208 related articles for article (PubMed ID: 7497797)
41. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
[TBL] [Abstract][Full Text] [Related]
42. Interstitial lung disease in polymyositis and dermatomyositis.
Schnabel A; Hellmich B; Gross WL
Curr Rheumatol Rep; 2005 Apr; 7(2):99-105. PubMed ID: 15760588
[TBL] [Abstract][Full Text] [Related]
43. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis].
Zuo C; Wei XD; Ye YL; Liang Y; Yin G; Yang M; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):801-4, 809. PubMed ID: 24325116
[TBL] [Abstract][Full Text] [Related]
44. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
Chen F; Shu XM; Wang DX; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
[TBL] [Abstract][Full Text] [Related]
45. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
46. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis.
Hayashi S; Tanaka M; Kobayashi H; Nakazono T; Satoh T; Fukuno Y; Aragane N; Tada Y; Koarada S; Ohta A; Nagasawa K
J Rheumatol; 2008 Feb; 35(2):260-9. PubMed ID: 18085731
[TBL] [Abstract][Full Text] [Related]
47. [Interstitial lung disease in polymyositis/dermatomyositis].
Schnabel A
Z Rheumatol; 2013 Apr; 72(3):220-6. PubMed ID: 23553021
[TBL] [Abstract][Full Text] [Related]
48. HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
Shu X; Peng Q; Lu X; Wang G
PLoS One; 2016; 11(8):e0161436. PubMed ID: 27537498
[TBL] [Abstract][Full Text] [Related]
49. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
50. Interstitial Lung Disease in Polymyositis and Dermatomyositis.
Long K; Danoff SK
Clin Chest Med; 2019 Sep; 40(3):561-572. PubMed ID: 31376891
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study.
Nakazawa M; Kaneko Y; Takeuchi T
Clin Rheumatol; 2018 Mar; 37(3):765-771. PubMed ID: 28975463
[TBL] [Abstract][Full Text] [Related]
52. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
53. The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis.
Kunimasa K; Arita M; Nakazawa T; Tanaka M; Tsubouchi K; Konishi S; Fukuda Y; Saigusa M; Nakagawa H; Ubukata S; Korogi Y; Fujii T; Mimori T; Ishida T
Intern Med; 2012; 51(24):3405-10. PubMed ID: 23257529
[TBL] [Abstract][Full Text] [Related]
54. Polymyositis-dermatomyositis-associated interstitial lung disease.
Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
[TBL] [Abstract][Full Text] [Related]
55. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
Xie MM; Yan X; Li H; Ding JJ; Gui XH; Liu Y; Wang YS; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug; 41(8):616-621. PubMed ID: 30138971
[No Abstract] [Full Text] [Related]
56. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis.
Huang ZG; Gao BX; Chen H; Yang MX; Chen XL; Yan R; Lu X; Shi KN; Chan Q; Wang GC
PLoS One; 2017; 12(7):e0181069. PubMed ID: 28715432
[TBL] [Abstract][Full Text] [Related]
57. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
[TBL] [Abstract][Full Text] [Related]
58. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
Chen YJ; Wu CY; Shen JL
Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
[TBL] [Abstract][Full Text] [Related]
59. [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy].
Li R; Li XP; Li XM; Wang GS; Qian L; Tao JH; Ma Y; Zhang H
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2335-8. PubMed ID: 23158563
[TBL] [Abstract][Full Text] [Related]
60. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation.
Arakawa H; Yamada H; Kurihara Y; Nakajima Y; Takeda A; Fukushima Y; Fujioka M
Chest; 2003 Apr; 123(4):1096-103. PubMed ID: 12684299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
